Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil and aniracetam in elderly subjects with subjective cognitive decline
NL-OMON48229Phase 1Recruiting
- Sponsor
- Purdue Pharma
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of modafinil and aniracetam in Memory complaint (SMC) (4 arms), sponsored by Purdue Pharma. Primary endpoint: Safety and tolerability. Started Sep 2019; status: recruiting.
02
Drugs
modafinilaniracetam
03
Conditions
Memory complaint (SMC)
Beyond the preview
Go deeper on NL-OMON48229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48229.